Provided by Tiger Fintech (Singapore) Pte. Ltd.

Revolution Medicines, Inc.

46.55
+0.31000.67%
Post-market: 46.980.4300+0.92%19:17 EDT
Volume:3.63M
Turnover:168.37M
Market Cap:8.70B
PE:-10.29
High:47.04
Open:46.80
Low:45.18
Close:46.24
52wk High:62.40
52wk Low:29.17
Shares:186.93M
Float Shares:158.56M
Volume Ratio:1.58
T/O Rate:2.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.5252
EPS(LYR):-3.5776
ROE:-46.61%
ROA:-26.47%
PB:4.66
PE(LYR):-13.01

Loading ...

Mar 02, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 03, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Feb 02, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Correspondence

CORRESP [Cover] - Correspondence
Feb 01, 2021

Correspondence

CORRESP [Cover] - Correspondence
Feb 01, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Feb 01, 2021

Major Issues Report

8-K - Current report
Nov 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2020

Major Issues Report

8-K - Current report
Aug 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2020

Major Issues Report

8-K - Current report
Jul 06, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jul 06, 2020

Correspondence

CORRESP [Cover] - Correspondence